Momekort Zur Anwendung Bei Erwachsenen (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momekort Zur Anwendung Bei Erwachsenen, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, seasonal and perennial forms, and nasal polyps in adult patients.

GNH USA supplies Momekort Zur Anwendung Bei Erwachsenen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate nasal spray is a topical corticosteroid that reduces inflammation in the nasal passages.

Allergic rhinitis: provides relief of nasal congestion, itching, sneezing and rhinorrhea. Seasonal allergic rhinitis: controls symptoms triggered by seasonal allergens. Perennial allergic rhinitis: maintains symptom control throughout the year. Nasal polyps: reduces polyp size and improves nasal airflow.

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Sore throat. - Unpleasant taste.

Serious or Rare Side Effects: - Severe nosebleeds. - Vision changes such as blurred vision or cataract formation.

Before using Momekort, consider the following precautions.

Pregnancy: consult a healthcare provider before use. Elderly: monitor for increased sensitivity to corticosteroid effects. Active nasal infection: avoid use until infection is resolved. Recent nasal or sinus surgery: discontinue before and after the procedure as advised. Store at room temperature: keep in the original container, protect from moisture and heat.

Momekort may interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic corticosteroids: may increase overall corticosteroid exposure. - Strong CYP3A4 inhibitors: may raise local drug concentration.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): potential increase in effect. - Ritonavir: may affect metabolism of mometasone. - Live nasal vaccines: nasal spray may reduce vaccine response.